Agree Hoofa. They'd be consolidating all the data points from the first cohort completIng/completed the 12 week 1503 trial by now. That will give them good indicative data to start discussions from now with potential partners (let's hope they're all like that Channel 7 feature).
Interesting discussion re partnering with 'big pharma v retail product companies'. It seems to me 1503 is better suited to the former, whereas 1701 better suits the latter.. (assuming 1701 still exists in Matt's bottom draw somewhere..)
Ann: Ethics Approval for BTX 1308 Psoriasis Patient Study Secured, page-104
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.0¢ |
Change
-0.010(2.78%) |
Mkt cap ! $707.4M | |||
| Open | High | Low | Value | Volume |
| 36.0¢ | 37.0¢ | 33.5¢ | $2.103M | 6.050M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 32406 | 34.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.0¢ | 234417 | 5 |
View Market Depth
| Last trade - 16.10pm 02/12/2024 (20 minute delay) ? |
| BOT (ASX) Chart |
